Skip to main content

Drug cuts breast cancer cases by more than 50 per cent in high risk women

Taking the breast cancer drug anastrozole for five years reduced the chances of post-menopausal women at high risk of breast cancer developing the disease by 53 per cent compared with women who took a placebo, according to a study published in the Lancet today.

Published on:
Back to top